- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/085 - Picornaviridae, e.g. coxsackie virus, echovirus, enterovirus
Patent holdings for IPC class C07K 14/085
Total number of patents in this class: 86
10-year publication summary
|
2
|
3
|
6
|
8
|
4
|
7
|
3
|
11
|
5
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Excepgen Inc. | 12 |
5 |
| Beijing Minhai Biotechnology Co., Ltd | 14 |
4 |
| Vactech Oy | 13 |
4 |
| Mayo Foundation for Medical Education and Research | 3212 |
3 |
| The Regents of the University of California | 19943 |
2 |
| Abbott Laboratories | 2405 |
2 |
| Centre National de La Recherche Scientifique | 10442 |
2 |
| Glaxosmithkline Biologicals S.A. | 1646 |
2 |
| California Institute of Technology | 3975 |
2 |
| The Trustees of the University of Pennsylvania | 4329 |
2 |
| Apodemus AB | 3 |
2 |
| Bionor Immuno AS | 20 |
2 |
| Cancer Research Technology Limited | 524 |
2 |
| Denka Company Limited | 2585 |
2 |
| King Faisal University | 917 |
2 |
| Medicago Inc. | 138 |
2 |
| Pharmaq AS | 78 |
2 |
| Universite de Strasbourg | 679 |
2 |
| TOMBLING, Adrian, George | 2 |
2 |
| Mink Therapeutics, Inc. | 18 |
2 |
| Other owners | 38 |